OUR RESOURCES

All of Biotech and Money's content, in one place.

Community Partners

EXECUTIVE PUBLICATIONS AND REPORTS

Attracting investment to the UK Life Sciences sector

Our Investor Perception Survey 2017 highlighted key trends around M&A, Inve...

Read More

Investment trends and outlook in 2017

Our Investor Perception Survey 2017 highlighted key trends around M&A, Inve...

Read More

Self-perpetuating myths and attitudes in the Biotech sector

There are several self-perpetuating myths and attitudes in the Biotech sect...

Read More

Issue 11, Drugs & Dealers Magazine Released

Biotech and Money are pleased to announce the release of the latest Drugs &...

Read More

[REPORT] Trends and Truth in Life Sciences Investment

We are delighted to announce the launch of Biotech and Money's Investor Per...

Read More

35+ Innovative Life Science Companies you'll want to meet in 2017

Who are the innovative biotech and medtech companies presenting at Biotech ...

Read More

The role of SFOs in the Healthcare Sector

Our ongoing mission at Biotech and Money is to forge a fundamentally better...

Read More

How Medtech Companies attract investment?

What are the key factors for medtechs to attract investment?

Read More
View More

EXECUTIVE AND EXPERT INSIGHTS

Interview with Dr Sara Nunez-Garcia, Principal, Sofinnova Partners

Phacilitate's Investment for Advanced Therapies in partnership with Biotech...

Read More

United Data in the United Kingdom: Congenica Diagnoses a Bright Future for UK Life Science Technologies

Tom Weaver CEO Congenica Using data analytics and applying their software t...

Read More

Open Window in the West? Deciding whether to pursue a US IPO

By Kristian Wiggert Partner Covington & Burling LLP, London The recent stro...

Read More

The impact of other people’s IP on you

This is the third in a series of four articles which aim to provide tips fo...

Read More

Eyeing up the global aesthetics market

Here are some lessons we learned during a recent interview with CFO Alan Ol...

Read More

10 things we learned from Medicines Discovery Catapult CEO Chris Molloy

With a strong focus on the collaboration needed to solve problems common to...

Read More

How to make your IP investable

This is the second in a series of four articles which aim to provide tips f...

Read More
View More